Omaxe Reports Steep FY26 Loss, Revenue Declines

Omaxe Limited reported a consolidated loss of ₹696.80 crore for the fiscal year ended March 31, 2026. Total consolidated income for FY26 fell 18.16% year-on-year to ₹1,339.74 crore.

Financial Results Disclosure

Omaxe Limited disclosed its financial results for the year ended March 31, 2026. The company recorded a consolidated loss of ₹696.80 crore for the full fiscal year, following a quarterly loss of ₹191.42 crore in Q4 FY26. Consolidated income declined 18.16% to ₹1,339.74 crore from ₹1,636.97 crore in the previous year. The company's standalone results showed a mixed performance: total income rose 14.38% to ₹514.67 crore, but the standalone annual loss widened to ₹195.61 crore.

Financial Health Concerns

The company's widening consolidated losses and declining revenues suggest significant challenges in its core business. Financial health is strained by deeply negative consolidated equity and a sharp increase in long-term borrowings.

Historical Context

Omaxe Limited has faced financial difficulties for several years, with past reports showing persistent losses and efforts to manage growing debt. Consolidated equity has eroded significantly, turning deeply negative and raising concerns about long-term viability.

Investor Outlook

Shareholders face ongoing uncertainty as the company grapples with profitability and mounting debt. This financial strain heightens the risk for investors. Any resolution to the pending SEBI order appeal could have implications, though the company states no current financial impact. The trend of rising consolidated debt requires careful monitoring.

Key Risks

• Deepening Losses: Continued significant losses at both standalone and consolidated levels, notably the large annual consolidated loss.
• Negative Equity: Consolidated 'Other Equity' fell to ₹(1,084.42) crore, a deficit in shareholder funds.
• Rising Debt Burden: Consolidated non-current borrowings more than doubled to ₹1,267.07 crore in one year.
• Regulatory Matter: An appeal against a SEBI order is pending at the Securities Appellate Tribunal (SAT), with the next hearing on July 7, 2026.

Comparison to Peers

Omaxe Ltd appears to be in a more difficult financial position compared to peers like DLF Ltd and Prestige Estates Projects Ltd. DLF consistently shows stronger profitability and debt management, while Prestige Estates has maintained revenue growth and profitability. This highlights divergent performance within the real estate sector.

Key Figures

• Consolidated total income for Q4 FY26 was ₹376.31 crore, down 31.95% from Q4 FY25.
• Consolidated net loss for FY26 was ₹696.80 crore, a change from the prior year.
• Consolidated non-current borrowings rose from ₹499.24 crore in FY25 to ₹1,267.07 crore in FY26.

Next Steps

• The outcome of the SEBI order appeal at the Securities Appellate Tribunal (SAT) on July 7, 2026.
• Future quarterly results to monitor sustained standalone revenue growth and any improvement in consolidated performance.
• Management commentary on debt reduction strategies and plans to address negative equity.
• Developments in the broader real estate market that could affect project sales and collections.